Tenon Medical Reports Q3 2026 Revenue Growth and Debt Elimination
Tenon Medical (TNON) reported a strong third quarter for 2026, with revenue reaching $1.4 million, a 22% increase year-over-year. This growth was primarily driven by the rising adoption of the company's Catamaran and Symmetry surgical systems, alongside successful early revenue from its titanium 3D-printed lateral screw technology. The company achieved a significant financial milestone by restructuring its balance sheet, raising $15.6 million in capital to fully retire its senior convertible notes. This move effectively eliminated total debt by the end of the quarter. While the company reported a net loss of $6.6 million due to noncash warrant inducement expenses, operating losses improved compared to the previous year. Looking forward, Tenon is focusing on commercial expansion through new leadership and an expanded salesforce. With $8.3 million in cash and cash equivalents and increased at-the-market capacity, the company is positioned to transition its R&D pipeline into broader commercial products.
Tickers: $TNON
Topics: gross margin improvement net loss operating expenses revenue growth